The Infectious Diseases Society of America has published a report, Bad Bugs No Drugs, which calls for a range of incentives to encourage greater R&D into antibiotics for infectious diseases.
CGD Policy Blogs
Jean-Francois Dehecq, Chairman and CEO of Sanofi-Aventis, set out the guiding principles of the group's policies on Access to Medicines at the BioVision conference.
The Group has identified 6 therapeutic areas for which concrete solutions can be envisioned: five curative therapeutic fields - malaria, leishmaniasis, sleeping sickness, tuberculosis and epilepsy - as well as the preventive field of vaccines.
According to the Voice of America, the head of UNAIDS, Peter Piot, says spending for HIV/AIDS programs in developing countries has increased from $200 million to more than $6 billion over the last eight years. Though he calls this encouraging, Dr. Piot says the big challenge is to get countries to make long-term commitments to funding to halt the spread of AIDS.
Africa needs more investment in research and manpower to boost vaccination rates that are less than half the global average, the director-general of the World Health Organization, Jong-Wook Lee, said on Wednesday.
Africa's vaccination coverage stood at around 30 percent, compared with a world coverage of more than 70 percent. The vaccines being used are also old. New investment is needed in research and development, but this is not really being done to a significant extent.
Here is the timetable, as far as we know it, for the G8 Summit in Gleneagles.
July 6-8, 2005
June 10-11, 2005
G7 Finance Ministers and Central Bank Governors Meeting, London
G7 Finance Ministers and Central Bank Governorns Meeting, Washington
Africa Partners Forum, Abuja, Nigeria
- Full text of Making Markets for Vaccines report
- Four page brief Making Markets for Vaccines
- FAQ on Making Markets for Vaccines
- Full transcript of launch of Making Markets for Vaccines
- Making Markets for Vaccines web page
- Making Markets for Vaccines Press Release
Today the House Foreign Operations Subcommittee, one of two subcommittees that will decide FY 2006 funding allocations for the Millennium Challenge Account, held a hearing on the MCA. The sole witness was MCC CEO Paul Applegarth.